Aligos股价上涨,因获得乙肝药物授权协议的首期付款

路透中文
Jul 07
BUZZ-Aligos股价上涨,因获得乙肝药物授权协议的首期付款

7月6日 - ** 生物技术公司Aligos Therapeutics(ALGS.O)的股价在盘后交易中飙升23.1%,至7.20美元

** ALGS表示,已根据与厦门阿莫托普生物科技(688278.SS)就培维福斯科维尔钠在大中华区达成的独家许可协议,收到2,500万美元预付款

** 根据协议条款,ALGS还有资格获得最高4.2亿美元的临床、监管及销售里程碑付款

** 培维福斯科维尔钠是ALGS的一款实验性乙型肝炎药物,旨在阻断病毒并降低疾病标志物

** 培维福斯科维尔钠已获得中国国家药品监督管理局药品审评中心(CDE)授予的“突破性疗法认定”

** ALGS今年迄今股价已下跌36.1%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10